Leveraging clinical experience specialized in dermatology
therapeutics and aesthetics, we provide customized
clinical trial solutions encompassing
quantitative evaluation and regulatory strategy.
Disease Treatments and Aesthetic Products
Chronic skin conditions such as atopic dermatitis, psoriasis, acne, and pigmentary disorders significantly impact quality of life, and the demand for long-term, safe therapeutic development continues to grow. Simultaneously, the global market for aesthetic products including botulinum toxin and dermal fillers is rapidly expanding, underscoring the importance of scientific evidence regarding drug mechanisms of action and treatment suitability.
Clinical development of skin disease treatments and aesthetic products must reflect the complex pathophysiological factors such as external environmental factors, genetic susceptibility, immune responses, and skin barrier function. Given the emphasis on visual and subjective evaluation criteria, standardization of assessment tools and ensuring data reliability are critical.
From the earliest stages of clinical trials, a scientific and quantitative approach is essential in terms of the pathophysiology of the target disease, efficacy assessment scales, and the establishment of dermatological biomarkers. For products such as botulinum toxin and dermal fillers in particular, precise clinical design is required for aspects including administration sites, treatment techniques, long-term efficacy, and safety evaluation. We strategically support the clinical development of skin disease and aesthetic treatment agents to achieve global competitiveness through statistical strategies, establishment of clinical trial participant selection criteria, and long-term follow-up design.
아We provide full-cycle clinical solutions based on our extensive clinical experience and expertise in the development of aesthetic treatments such as botulinum toxin, fillers, and skin regeneration agents, as well as chronic skin diseases such as atopic dermatitis, psoriasis, acne, and urticaria.
Considering the pathophysiology of skin diseases and the mechanisms of immune and inflammatory responses, we design customized protocols, establish evaluation metrics for safety and efficacy assessments, and provide systematic support from the initial strategic planning stage. Drawing on the expertise of medical doctors, pharmacists, nurses, biotechnologists, and clinical statisticians, we conduct clinical trials by comprehensively considering pharmacokinetic/pharmacodynamic (PK/PD) information, image-based quantitative analysis, and patient-reported outcome measures (PROMs).
Skin disease treatments and aesthetic products are developed in various forms, including drugs, medical devices, injectables, fillers, and combination formulations, and the regulatory frameworks and quality standards that apply to each product type vary.
C&R provides professional services across the entire process, not only in clinical trial operations but also in data management, statistical analysis, and preparation of submission materials for regulatory authorities, supporting reliable clinical development at a global standard.
clinical development with C&R Research.